Incidence and duration of common, early-onset adverse events occurring during 2 randomized, placebo-controlled, phase 3 studies of sodium oxybate in participants with narcolepsy

STUDY OBJECTIVES: To determine the time course and duration of common, early-onset treatment-emergent adverse events (TEAEs) associated with sodium oxybate (SXB) use in adults with narcolepsy. METHODS: These were post hoc analyses of two 8-week, randomized, double-blind, placebo-controlled trials. I...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Sleep Med
Autori principali: Husain, Aatif M., Bujanover, Shay, Ryan, Robert, Scheckner, Brian, Black, Jed, Profant, Judi
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Academy of Sleep Medicine 2020
Soggetti:
Scientific Investigations
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7970612/
https://ncbi.nlm.nih.gov/pubmed/32356515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5664/jcsm.8530
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi